CLEOCIN T SUMMARY
CLEOCIN T Topical Solution and CLEOCIN T Topical Lotion contain clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. CLEOCIN T Topical Gel contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram. Each CLEOCIN T Topical Solution pledget applicator contains approximately 1 mL of topical solution.
CLEOCIN T Topical Solution, CLEOCIN T Topical Gel and CLEOCIN T Topical Lotion are indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate. (See CONTRAINDICATIONS, WARNINGS and ADVERSE REACTIONS.)
Published Studies Related to Cleocin T (Clindamycin Topical)
Efficacy of clindamycin in reducing pain following tonsillectomy in adults: a
double-blind, randomised trial. 
reducing throat pain after tonsillectomy in adult patients... CONCLUSION: Topical clindamycin was not demonstrated to be more effective than
Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne
Nicotinamide and clindamycin gels are two popular topical medications for acne
vulgaris... Skin type is a significant factor in choosing
between topical nicotinamide and clindamycin in patients with acne vulgaris.
A randomized, double-blind, placebo-controlled, pilot study to assess the
efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for
the treatment of acne rosacea over 12 weeks. 
rosacea after 12 weeks of usage... CONCLUSIONS: A combination gel of clindamycin phosphate 1.2% and tretinoin 0.025%
Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial. [2011.11]
BACKGROUND: Topical therapy with comedolytics and antibiotics are often advocated for mild and moderate severity acne vulgaris. Nadifloxacin, a new fluoroquinolone with anti-Propionibacterium acnes activity and additional anti-inflammatory activity, is approved for use in acne. This randomized controlled assessor blind trial compared the clinical effectiveness and safety of eight weeks therapy of nadifloxacin 1% versus clindamycin 1% as add-on therapy to benzoyl peroxide (2.5%) in mild to moderate grade acne... CONCLUSIONS: Topical nadifloxacin, a new fluoroquinolone is effective, tolerable, and safe for mild o moderate facial acne. Its clinical effectiveness is comparable to clindamycin when used as add-on therapy to benzoyl peroxide.
Solid state NMR and bioequivalence comparison of the pharmacokinetic parameters of two formulations of clindamycin. [2011.07]
OBJECTIVE: The purpose of this study was to compare the pharmacokinetic parameters and determine the bioequivalence of a generic formulation of clindamycin that is sold in the local markets in the Middle East (Clindox(R) 150 mg capsule; test) with a reference formulation (Dalacin C(R) 150 mg capsule) in healthy adult male volunteers... CONCLUSION: The statistical comparison suggested that Clindox(R) capsules are bioequivalent to Dalacin C(R) capsules. The 13C CPMAS results confirmed that the two drugs exhibit typical clindamycin spectra.
Clinical Trials Related to Cleocin T (Clindamycin Topical)
Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate [Not yet recruiting]
The aim of this study is to evaluate the role of clindamycin and artesunate as possible
combination partners for fosmidomycin to protect it from its susceptibility to recrudescent
infections when used as monotherapy for acute Plasmodium falciparum malaria while retaining
its excellent safety profile
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea [Recruiting]
The purpose of this study is to determine whether Clindamycin Phosphate 1. 2% And Tretinoin
0. 025% Gel are effective and safe in the treatment of papulopustular rosacea.
Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects [Not yet recruiting]
The main purpose of this study is to compare the safety and efficacy of tigecycline versus
clindamycin (including subjects treated with vancomycin) in pediatric subjects (aged 8 to 17
years) with complicated skin and skin structure infections (cSSSI), including those caused
by methicillin-resistant staphylococcus aureus (MRSA).
Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer [Recruiting]
The purpose of this trial is to determine if rash caused by erlotinib can be successfully
treated and if so to determine the optimal treatment approach.
Hypothesis 1: If the incidence of rash is 50% while on erlotinib, prophylactic monotherapy
with minocycline can prevent occurrence in 50% of these patients.
Hypothesis 2: Treatment of rash is successful in improving rash by at least one Grade in 80%
Hypothesis 3: In patients with untreated rash, the rash will be self-limiting in 25% of
patients, and 65% will be grade 1, 2A, and 2b. Ten percent will be grade 3 requiring
treatment with monotherapy intervention.
Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies [Recruiting]
Abnormal vaginal flora is a risk factor for preterm labor. Therefore, in high risk
pregnancies for preterm labor the diagnosis and treatment of abnormal flora is indicated.
Clindamycin and metronidazole given orally are both acceptable treatments in these cases.
The purpose of this study is to compare the effectiveness of Clindamycin Vs metronidazole
for the treatment of abnormal vaginal flora in high risk pregnancies. For this purpose,
pregnant women who are considered high risk for preterm labor and were diagnosed with
abnormal vaginal flora will be randomly treated either with clindamycin or metronidazole.
Eradication of the abnormal flora and adverse effects will be monitored and compared